ELUTE fibre aims to directly replace traditional fibres in medical textiles to potentially improve clinical outcomes by delivering temperature sensitive therapeutics and live biologics directly at the site of implant.

Visitors to Neuroscience 2016 are encouraged to explore how TissueGen’s patented manufacturing process enables controlled sustained delivery of the broadest range of temperature-sensitive pharmaceuticals and biologics ever possible via biodegradable fibre-based devices to enable medical device developers to achieve breakthroughs across a broad range of medical applications.

TissueGen works with leading pharmaceutical, therapeutic, and medical device companies to develop fibre and textile medical devices for use in drug delivery applications such as small diameter vascular grafts and stents, tissue and nerve regeneration, orthopedic devices and sutures.

TissueGen has more than four decades of cumulative experience in extruding biodegradable polymer fibres with broad drug delivery capabilities. ELUTE fibre can directly replace standard fibres used in biodegradable textiles currently on the market and provide significantly improved clinical outcomes by delivering therapeutic agents directly at the site of the implant.  By delivering drugs and growth factors at the site of implantation, ELUTE fiber enables medical devices to guide the body’s healing and regenerative processes.

www.tissuegen.com.

Neuroscience 2016

Booth 3013

San Diego Convention Center

111 West Harbor Drive

San Diego, CA 92101